VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 536 filers reported holding VANECK VECTORS ETF TR in Q4 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $320,000 | -8.0% | 8,885 | 0.0% | 0.12% | -10.9% |
| Q3 2020 | $348,000 | +13.0% | 8,885 | +6.0% | 0.13% | +7.5% |
| Q2 2020 | $308,000 | +59.6% | 8,385 | 0.0% | 0.12% | +34.8% |
| Q1 2020 | $193,000 | -12.3% | 8,385 | +11.8% | 0.09% | +17.1% |
| Q4 2019 | $220,000 | +10.0% | 7,500 | 0.0% | 0.08% | +11.8% |
| Q3 2019 | $200,000 | +212.5% | 7,500 | +200.0% | 0.07% | +223.8% |
| Q2 2019 | $64,000 | +190.9% | 2,500 | +150.0% | 0.02% | +200.0% |
| Q1 2019 | $22,000 | +4.8% | 1,000 | 0.0% | 0.01% | -12.5% |
| Q4 2018 | $21,000 | +50.0% | 1,000 | +88.7% | 0.01% | +166.7% |
| Q3 2016 | $14,000 | -6.7% | 530 | 0.0% | 0.00% | -25.0% |
| Q2 2016 | $15,000 | – | 530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |